Engineers Gate Manager LP Omeros Corp Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.08 - $3.63 $17,204 - $57,825	15,930 New	15,930 $52,000
Q2 2023 Aug 14, 2023	BUY	$4.45 - $7.57 $126,825 - $215,745	28,500 New	28,500 $155,000
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $255,152 - $362,347	-50,326 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $285,348 - $429,784	50,326 New	50,326 $324,000
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $479,267 - $717,955	-47,265 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $452,326 - $1.01 Million	47,265 New	47,265 $478,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $647M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.